Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Week Liechtenstein.
Press releases published on October 3, 2025
Frontier Medicines Announces Publication in Structure Highlighting Novel E3 Ligase DCAF2 can be Harnessed for Targeted Protein Degradation
- First report of high-resolution structures of DCAF2 - - Frontier™ Platform key to discovering covalent ligands to selectively target DCAF2 - BOSTON and SOUTH SAN FRANCISCO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a …
AKATI Sekurity Named 2025 AI MSP of the Year at Channel Futures MSP 501 Gala
Kuala Lumpur, Malaysia, Oct. 03, 2025 (GLOBE NEWSWIRE) -- AKATI Sekurity, an award-winning MSSP, announced today that it has been named a 2025 MSP 501 AI MSP of the Year at the prestigious Channel Futures MSP 501 Gala held in Orlando, Florida on September …
Pro Web Services Launches AI-Powered Chatbot for Dental Clinics, First Integration at Westcoast Smile Dental
VANCOUVER, British Columbia, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Pro Web Services (PWS), the registered trade name of Multiaxis Enterprise Inc., today announced the launch of its new AI-powered chatbot designed specifically for dental clinics. The solution …
Pro Web Services lance un chatbot alimenté par l’IA pour les cliniques dentaires, première intégration avec Westcoast Smile Dental
VANCOUVER, Colombie-Britannique, 03 oct. 2025 (GLOBE NEWSWIRE) -- Pro Web Services (PWS), le nom commercial enregistré de Multiaxis Enterprise Inc., a annoncé aujourd’hui le lancement de son nouveau chatbot alimenté par l’intelligence artificielle, conçu …
Akari Therapeutics Announces Abstract Accepted for Oral Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting
BOSTON and LONDON, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced its abstract has been accepted for oral presentation at …
Global Preclinical Imaging Market Set to Reach USD 5.101 Million by 2029 | MarketsandMarkets™
Delray Beach, FL, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The global preclinical imaging market, valued at US$3.807 million in 2023, stood at US$3.997 million in 2024 and is projected to advance at a resilient CAGR of 5.0% from 2024 to 2029, culminating in a …
Youxin Technology Ltd Regains Compliance with Nasdaq Stockholders’ Equity Rule
GUANGZHOU, CHINA, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (Nasdaq: YAAS) (the “Company” or “Youxin Technology”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally …
Antimony Market in The U.S. Projected To Grow Significantly as Critical Minerals are Becoming Vital Across Many Sectors
PALM BEACH, Fla., Oct. 03, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global Antimony market is expected to continue the substantial growth it has seen in recent years. A report from Fortune Business Insights said that: “The global …
Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
REDWOOD CITY, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS), today announced an upcoming poster presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) being held November 5-9, 2025, in …
Candel Therapeutics to Present at the SITC 2025 Annual Meeting
NEEDHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Company will share data demonstrating CD47 overexpression as key predictive biomarker for response with the Company’s lead candidate, evorpacept, in HER2+ gastric cancer SOUTH SAN FRANCISCO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings …
Antimony Spot Price Has Yet Again Achieved a New All-Time High as Critical Minerals Demand Jumps
PALM BEACH, Fla., Oct. 03, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Antimony is vital for many industries, including batteries, solar panels, flame retardants, and ammunition. Antimony sulfide, or Stibnite, is the principal ore of antimony …
Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting
New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting The data will be the latest of many additions to EVX-01’s strong data package Two-year …
Enara Bio to Reveal DARKFOX, a Novel Cancer-Specific Dark Antigen with Broad-Ranging Therapeutic Potential, in Oral Presentation at SITC 2025
Oxford, United Kingdom – October 3, 2025. Enara Bio, a biopharmaceutical company pioneering the discovery of novel Dark Antigens® and the development of bispecific T cell engagers for solid tumors, will present two abstracts related to the significant …
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
WATERTOWN, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …
Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
WALTHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced multiple …
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics using its proprietary CAB platform for the …
Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off
ALAMEDA, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced that the Company will …
Network Tokens cut credit card fraud declines in emerging markets by 86%, EBANX reports
CURITIBA, Brazil, Oct. 03, 2025 (GLOBE NEWSWIRE) -- EBANX, a global technology company specializing in payment services for emerging markets, reports that the use of Network Tokens (NT) has reduced credit card declines due to fraud and security issues by …
InfraX to Launch Exchange for Workload Compute Unit (WCU) Financial Products
CHARLOTTE, N.C. and CHICAGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- InfraX™, a new exchange being spun out from InfraSight Software Corporation, today announced its mission to list and trade financial products for the Workload Compute Unit (WCU-Hour). Co- …